Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis.

Lee, W R; Hanks, G E; Schultheiss, T E; Corn, B W; Hunt, M A

Lee, W R; Hanks, G E; Schultheiss, T E; Corn, B W; Hunt, M A.

Affiliation

Lee WR; Fox Chase Cancer Center, Department of Radiation Oncology, Philadelphia, PA 19111.

J Clin Oncol ; 13(2): 464-9, 1995 Feb.

Article in En | MEDLINE | ID: mdl-7531222

Subject(s)

Prostate-Specific Antigen/blood; Prostatic Neoplasms/radiotherapy; Aged; Aged, 80 and over; Biomarkers; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Prostatic Neoplasms/diagnosis; Prostatic Neoplasms/mortality; Survival Rate; Time Factors; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prostate-Specific Antigen Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1995 Type: Article

Search on Google

XML

PubMed Links